Genitope Encouraged By Positive Progression-Free Survival “Trend” In Phase III MyVax Trial
This article was originally published in The Pink Sheet Daily
Executive Summary
Final data on the personalized cancer vaccine’s use in non-Hodgkin’s lymphoma are expected in November.